NEWS
![[Etoday] C&R Research Conducts Global Clinical Trials For Shaperon Atopic Dermatitis Treatment ‘NuGel’](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Etoday] C&R Research conducts global clinical trials for Shaperon atopic dermatitis treatment ‘NuGel’
2023-09-18
C&R Research announced on the 18th that it has decided to conduct a global clinical trial with Shaperon and InHandPlus.…
[Newsprime] C&R Research Strengthens Dementia Disease Clinical Trial Services
2023-09-13
[Newsprime] C&R Research (359090), Korea's first commissioned clinical trial (CRO) company, conducted strategic work for joint academic research and technological…
[Hankyung] C&R Research “Enter into the U.S. clinical agency market within the year”
2023-08-14
Vision for Korea’s ‘No. 1’ CRO company Established a local branch and received project orders Standardize your data with your…
[Etoday] C&R Research expands performance in the first half of the year… Sales KRW 25.6 billion
2023-08-14
C&R Research, a clinical trial consignment agency, achieved its highest performance since listing. C&R Research announced on the 14th that…
[Hankyung] C&R Research helps develop treatments for rare diseases through ‘external control group’
2023-07-27
C&R Research, Korea's first contract research organization (CRO) company, supports the development of treatments for rare and incurable diseases…